Salubris Pharmaceuticals Limited

• Quy mô

  1.000-4.999 nhân viên

• Lĩnh vực

  Dược phẩm

• Liên hệ

  Mr. Robin

Salubris Pharmaceuticals Limited a US Dollar 5-billion international pharmaceutical group, founded in 1998 and listed on the Shenzhen Stock Exchange in 2009 (stock code: 002294). Our business is Innovation-driven, with 48 patented products in development. Our R&D centers in China and Maryland, USA subsidiary cover the whole industry chain and connect global innovative resources to study pathogenesis, explore therapies and develop patented pharmaceuticals. For high Quality products, we have 8 manufacturing sites. Our Baoan site produces sterile cephalosporin APIs and formulations, both received PICS GMP inspection and certification again from Brazilian ANVISA earlier this year. Our newer Shandong site will be receiving European Inspection next year. Our oral solid dosage site passed European inspection. Our parenteral solution and lyophilization workshops also passed European inspection. Keeping promises is the source of happiness. Our most important business is You！ Serving people in health and sickness. Advancing medical knowledge in partnership with healthcare professionals. Working with partners and regulators to take products to market. Worldwide, we serve customers in over 40 countries. Within China, our team of 2 thousand medical representatives, serving 13 thousand hospitals and 110 thousand pharmacies. With integrated services, we can meet market needs. Strong partnership with you is our priority.